LB Pharmaceuticals Inc Common Stock LBRX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $27.97M— | $16.74M— | $8.64M— | $16.88M— | —— | ||
| $18.11M— | $13.66M— | $13.44M— | $16.03M— | —— | ||
| $46.08M— | $30.4M— | $22.07M— | $32.91M— | —— | ||
| $7.14M— | $5.21M— | $3.28M— | $3.49M— | —— | ||
| -$38.95M— | -$25.2M— | -$18.8M— | -$29.43M— | —— | ||
| $1K— | $1K— | $1K— | $1K— | —— | ||
| -$38.95M+25.4% | -$25.2M+60.1% | -$18.8M— | -$29.43M— | -$52.19M— | ||
| —— | —— | —— | —— | —— | ||
| -$38.63M— | -$24.88M— | -$18.54M— | -$29.22M— | —— | ||
| -$38.95M— | -$25.2M— | -$18.8M— | -$29.43M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is LB Pharmaceuticals Inc Common Stock profitable?
- LB Pharmaceuticals Inc Common Stock is not currently profitable: it reported a net loss of $39.0M over the trailing twelve months.
- What is LB Pharmaceuticals Inc Common Stock's earnings per share?
- LB Pharmaceuticals Inc Common Stock's diluted EPS over the trailing twelve months is $-30.07.
- Where does LB Pharmaceuticals Inc Common Stock's income statement data come from?
- Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.